The blood-testing device producer, which counts Access Industries and Haisco as investors, has added $28m to its coffers.
Sight Diagnostics, an Israel-based medical diagnostics device developer backed by conglomerate Access Industries, has secured $28m from unnamed investors, Globes has reported, citing news from Access subsidiary Clal Biotechnology Industries.
Although the investors were not disclosed, announcement stated that Anatomy, a fund 50% held by Clal Biotechnology, will own a 7% stake in Sight once the round has closed.
Founded in 2011, Sight Diagnostics has created a machine learning-equipped system that allows doctors to test a patient’s blood in the…
